VIRAL EVASION STRATEGIES: ANALYSIS OF HERPES VIRUSES HSV, VZV AND HHV-6-7
病毒逃避策略:疱疹病毒 HSV、VZV 和 HHV-6-7 分析
基本信息
- 批准号:7214723
- 负责人:
- 金额:$ 36.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:AllelesAnimal ModelAnimalsAntigen PresentationAntigensBase SequenceBiologicalCD8B1 geneClassClinicalCollectionComplementCytomegalovirusCytomegalovirus InfectionsElementsEthnic groupFaceFlu matrix proteinFrequenciesGene TargetingGenerationsGenesHLA-A2 AntigenHLA-B7 AntigenHerpesviridaeHistocompatibility Antigens Class IHumanImmuneImmune systemIn VitroInfectionKnock-in MouseLifeMHC Class I GenesMembrane GlycoproteinsMusNumbersPopulationPropertyProteinsReactionRecombinantsRoleShapesSimplexvirusStructureSuggestionSystemT-LymphocyteTransgenic MiceTubulinViralVirusin vivolatent infectionmouse modelpathogenpeptide Irecombinant virusresponsetissue culture
项目摘要
Human Herpesviruses cause a life-long latent infection, from which reactivation can occur in the face of a fully primed immune system. This viral strategy necessitates evasion of host immune reactions. For human cytomegalovirus (HCMV), a set of genes in the unique short (US) region encode a collection of in all likelihood structurally similar-type I membrane glycoproteins. Several of these genes, notably US2, US3, US6 and US 11, are known to interfere with MHC class I restricted antigen presentation when analyzed in tissue culture systems. To complement the recent determination of the Class I-US2 structure we have initiated structural studies of the HCMV US3 product. We shall further analyze the mode of action and structure of U21, an HHV7-encoded immunoevasin that also down-regulates MHC class I molecules. Because there is no animal model for HCMV infection, the suggestions for the biological role of the immunoevasins encoded in the HCMV US cluster remain conjectural. Murine CMV recombinants equipped with the US genes, alone or in combination, will be generated, along with the flu matrix protein, which will serve as the "passenger" antigen to allow enumeration of antigen-specific T cells. With these viruses we shall infect HLA-A2 and I-ILA-B7 transgenic mice in which the endogenous H-2K and H-2D genes have been disrupted through gene targeting. These animals must rely on the human restriction elements for the generation of CD8 T cells, the presence and frequency of which will be determined with the appropriate HLA-Class I peptide tetramers. In view of the intimate connection between the US gene products and MHC class I antigens, the nucleotide sequence of the US2, US3, US6 and US 11 genes will be determined for a number of clinical HCMV isolates, to be obtained preferably from different ethnic groups with different sets and distributions of MHC class I alleles. This analysis should reveal if and to what extent the MHC alleles in the human population help shape the "repertoire" of immunoevasins.
人类疱疹病毒会导致终身潜伏感染,在完全启动的免疫系统面前,可能会发生重新激活。这种病毒策略需要逃避宿主的免疫反应。对于人类巨细胞病毒(HCMV)来说,独特的短(US)区的一组基因编码一组结构上非常相似的I型膜糖蛋白。其中几个基因,特别是US2、US3、US6和US11,在组织培养系统中分析时,已知干扰MHC I类限制性抗原提呈。为了补充最近对I-US2类结构的确定,我们启动了对HCMV US3产物的结构研究。我们将进一步分析U21的作用模式和结构,U21是一种HHV7编码的免疫血管蛋白,也下调MHC I类分子。由于目前还没有人巨细胞病毒感染的动物模型,因此关于巨细胞病毒US簇中编码的免疫因子的生物学作用的建议仍然是推测的。将产生单独或组合配备US基因的小鼠CMV重组体,以及流感基质蛋白,该蛋白将作为“乘客”抗原,允许计数抗原特异性T细胞。用这些病毒感染内源性H-2K和H-2D基因已被基因打靶打乱的人类白细胞抗原A2和I-ILA-B7转基因小鼠。这些动物必须依靠人类的限制因素来产生CD8T细胞,CD8T细胞的存在和频率将由适当的人类白细胞抗原-I类多肽四聚体来确定。鉴于US基因产物与MHC I类抗原之间的密切联系,将确定一些临床分离株的US2、US3、US6和US11基因的核苷酸序列,最好从具有不同MHC I类等位基因集合和分布的不同种族中获得。这项分析应该会揭示人类群体中的MHC等位基因是否以及在多大程度上帮助形成了免疫球蛋白的“曲目”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hidde L. Ploegh其他文献
Translating cell biology in vitro to immunity in vivo
将体外细胞生物学转化为体内免疫
- DOI:
10.1038/nature02762 - 发表时间:
2004-07-08 - 期刊:
- 影响因子:48.500
- 作者:
Marianne Boes;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Procédés de ligature et utilisations associées
结扎与应用协会程序
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
Hidde L. Ploegh;John M. Antos;Maximilian Wei;Carla P. Guimaraes - 通讯作者:
Carla P. Guimaraes
A mouse monoclonal antibody against Alexa Fluor 647.
针对 Alexa Fluor 647 的小鼠单克隆抗体。
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Irene Wuethrich;E. Guillén;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
Sec61 介导的膜蛋白从内质网转移到蛋白酶体进行降解
- DOI:
10.1038/384432a0 - 发表时间:
1996-12-05 - 期刊:
- 影响因子:48.500
- 作者:
Emmanuel J. H. J. Wiertz;Domenico Tortorella;Matthew Bogyo;Joyce Yu;Walther Mothes;Thomas R. Jones;Tom A. Rapoport;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
基于纳米抗体的双特异性抗体衔接子靶向 CTLA-4 或 PD-L1 用于癌症免疫治疗
- DOI:
10.1038/s41551-025-01447-z - 发表时间:
2025-07-16 - 期刊:
- 影响因子:26.600
- 作者:
Xin Liu;Camille Le Gall;Ryan K. Alexander;Ella Borgman;Thomas Balligand;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Hidde L. Ploegh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hidde L. Ploegh', 18)}}的其他基金
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10464850 - 财政年份:2021
- 资助金额:
$ 36.98万 - 项目类别:
Non-invasive imaging of the anti-tumor immune response
抗肿瘤免疫反应的非侵入性成像
- 批准号:
10520018 - 财政年份:2020
- 资助金额:
$ 36.98万 - 项目类别:
Non-invasive imaging of the anti-tumor immune response
抗肿瘤免疫反应的非侵入性成像
- 批准号:
10318578 - 财政年份:2020
- 资助金额:
$ 36.98万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10461021 - 财政年份:2019
- 资助金额:
$ 36.98万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10208670 - 财政年份:2019
- 资助金额:
$ 36.98万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10671648 - 财政年份:2019
- 资助金额:
$ 36.98万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10002176 - 财政年份:2019
- 资助金额:
$ 36.98万 - 项目类别:
Non-invasive imaging of the immune response based on the use of isotopically labeled single domain antibody fragments
基于使用同位素标记的单域抗体片段的免疫反应的非侵入性成像
- 批准号:
8873207 - 财政年份:2015
- 资助金额:
$ 36.98万 - 项目类别:
Sortase-mediated installation of recognition modules on T cells for redirected ki
分选酶介导在 T 细胞上安装识别模块以实现重定向 ki
- 批准号:
8683479 - 财政年份:2014
- 资助金额:
$ 36.98万 - 项目类别:
Endosomal TLRs and their accessory proteins: cell biology and biochemistry
内体 TLR 及其辅助蛋白:细胞生物学和生物化学
- 批准号:
8454409 - 财政年份:2012
- 资助金额:
$ 36.98万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 36.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists